Clinical Trials - Medical Center Ophthalmology Associates
Diabetes, unfortunately, is a common medical condition. Diabetes can cause a multitude of health issues and one of the most common is, Diabetic Eye Disease. At MCOA, we strive to better treat and one day stop the spread of diabetic eye disease through our Clinical Trials.
Diabetes, Diabetic Eye Disease, Diabetic Eye Surgery, Diabetic Retinopathy, Studies for diabetes, Glaucoma, Dry Eyes
page-template-default,page,page-id-17256,ajax_fade,page_not_loaded,,qode-title-hidden,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-4.11.2,vc_responsive

MCOA is dedicated to advancing the field of Ophthalmology through research, clinical studies and the development of new instruments and techniques. We are engaged in multiple clinical research trials of new therapies for various ophthalmological diseases. You will find information about some of these studies below.


Wet Age-Related Macular Degeneration 

Allergan Cedar – Phase 3 study for wet age-related macular degeneration

Daiichi – Phase 1 Dose Escalation and Expansion Study of DS-7080a in Subjects With Neovascular Age-related Macular Degeneration

Genentech Ladder – Phase 3 Port sustained delivery system of Ranibizumab for Patients with Wet nAmd

Ohr MAKO – Phase 3 study for wet age-related macular degeneration


Diabetic Macular Edema 

Allegro DME –  A Phase 2, Multi-Center, Randomized, Controlled, Double-Masked Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate (ALD-1001) as Compared to Avastin in the Treatment of Diabetic Macular Edema

Roche Boulevard DME – A phase 2 study for diabetic macular edema


Anterior Uveitis

Eyegate – A Prospective, Multi-Center, Randomized Double-Masked, Positive- Controlled, Phase 3 Clinical Trial Designed to Evaluate the Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution Compared to Prednisolone Acetate Ophthalmic Suspension (1%) in Patients with Non-Infectious Anterior Segment Uveitis


Diabetic Retinopathy

Regeneron Panorama – A phase 3 study for diabetic retinopathy


A typical clinical trial visit could include the following:

* Note all Procedures are protocol dependent *

  • Informed Consent Process
  • Visual Acuity Testing or Vision Exam
  • Optical Coherence Tomography (OCT)
  • Fundus Photography
  • Fluorescein Angiogram
  • Blood / Lab Work
  • Vitals
  • Exam with Ophthalmologist


Participants of MCOA clinical research will have the newest treatments available to treat related eye problems. We have an expert team comprised of knowledgeable doctors and staff, who will follow you through the trial process. Many of today’s complex eye diseases are genetic and do not yet have effective treatments. Our research is leading the way for new effective ways to treat current eye diseases. There are many benefits to participating in a clinical trial with us.

If you or someone you know is interested in finding out more, please contact us by either calling our Clinical Trials department at 210-697-2006, our main number at 210-697-2020 or email us.